AGC Biologics Shifts Leadership Structure at United States and Copenhagen Sites to Support the Continued Development and Growth of the Regions
SEATTLE, Oct. 15, 2020 /PRNewswire/ — AGC Biologics, a leading global biopharmaceutical contract development and manufacturing organization (CDMO), has announced